Viamet Pharmaceuticals, Inc.

Release Summary

Viamet announces the presentation of multiple studies supporting VT-1598, a clinical-stage compound for the treatment of life-threatening invasive fungal infections, took place at ASM Microbe 2017.

Viamet Pharmaceuticals, Inc.